Additive effects of common and rare genetic variants on inflammatory bowel disease risk in a cohort with immunodeficiency
Authors:
- 27 February 2026
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 157 (6) , 1457-1460
Abstract
No abstract availableKeywords
Funding Information
- Division of Intramural Research
This publication has 10 references indexed in Scilit:
- Evaluation of polygenic scoring methods in five biobanks shows larger variation between biobanks than methods and finds benefits of ensemble learningThe American Journal of Human Genetics, 2024
- Polygenic risk alters the penetrance of monogenic kidney diseaseNature Communications, 2023
- Polygenic Background Modifies Risk of Coronary Artery Disease Among Individuals With Heterozygous Familial HypercholesterolemiaJACC: Advances, 2023
- Understanding inborn errors of immunity: A lens into the pathophysiology of monogenic inflammatory bowel diseaseFrontiers in Immunology, 2022
- Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert CommitteeJournal of Clinical Immunology, 2022
- Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET RegistryThe Journal of Allergy and Clinical Immunology: In Practice, 2022
- Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel diseaseThe American Journal of Human Genetics, 2021
- Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditionsNature Communications, 2020
- Human inborn errors of immunity: An expanding universeScience Immunology, 2020
- Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohnʼs Disease Development in Chronic Granulomatous DiseaseInflammatory Bowel Diseases, 2016